Clinical Trials Directory

Trials / Completed

CompletedNCT03352362

Comparison of the Effect of Propacetamol, Ibuprofen or Their Combination on Postoperative Pain and Quality of Recovery After Laparoscopic Hernia Repair in Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
159 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
6 Months – 6 Years
Healthy volunteers
Not accepted

Summary

There are difficulties in the progress of the study and cancel the plan. The purpose of this study is to evaluate the postoperative pain control using non - opioidal analgesics in children. The investigators will investigate the effect of single use and combination of caldorol(ibuprofen) compare to denogan(propacetamol) in children. Participants who receive the laparoscopic inguinal hernia repair between 6 months and 6 years old are divided 3 groups(caldolor, denogan, combination). Each groups are received a medication by protocol during surgery. After operation patient's pain score and use of additional analgesics are recorded in postanesthesia care unit and general ward.

Conditions

Interventions

TypeNameDescription
DRUGibuprofen (caldolor 10 mg / kg)Dilution caldolor 10 mg / kg in Hartmann solution to 50 mL - 100 mL and intravenous injection for 30 minutes immediately after induction of anesthesia
DRUGpropacetamol (denogan 30 mg / kg)Dilution denogan 30 mg / kg in the dissolved solution to a total of 10 ml and intravenous injection for 10 minutes after the main surgical procedure end
DRUGibuprofen + propacetamolDilution caldolor 10 mg / kg in Hartmann solution to 50 mL - 100 mL and intravenous injection for 30 minutes immediately after induction of anesthesia Dilution denogan 30 mg / kg in the dissolved solution to a total of 10 ml and intravenous injection for 10 minutes after the main surgical procedure end

Timeline

Start date
2017-12-15
Primary completion
2019-03-08
Completion
2019-03-09
First posted
2017-11-24
Last updated
2019-05-06

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03352362. Inclusion in this directory is not an endorsement.